Hematopathology — MCQs

Hematopathology Indian Medical PG Practice Questions and MCQs

Question 991: ADAMTS13 deficiency is seen in which condition?

A. Thrombotic thrombocytopenic purpura (TTP) (Correct Answer)
B. Hemolytic uremic syndrome (HUS)
C. Wegener's granulomatosis
D. Membranous nephropathy

Explanation: **Explanation:** **ADAMTS13** (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is a plasma enzyme responsible for cleaving large **von Willebrand Factor (vWF) multimers** into smaller, less active fragments. 1. **Why Option A is Correct:** In **Thrombotic Thrombocytopenic Purpura (TTP)**, there is a deficiency of ADAMTS13 (either congenital or, more commonly, acquired via autoantibodies) [1]. This leads to the persistence of "ultra-large" vWF multimers, which cause spontaneous platelet aggregation and microthrombi formation. This results in microangiopathic hemolytic anemia (MAHA) and thrombocytopenia [2]. 2. **Why Other Options are Incorrect:** * **Hemolytic Uremic Syndrome (HUS):** While clinically similar to TTP, HUS is typically caused by **Shiga toxin** (from *E. coli* O157:H7), which damages endothelial cells [3]. ADAMTS13 levels are usually normal in HUS [1]. * **Wegener’s Granulomatosis (GPA):** This is a small-vessel vasculitis associated with **c-ANCA (PR3-ANCA)**, characterized by granulomatous inflammation of the respiratory tract and kidneys. * **Membranous Nephropathy:** This is a nephrotic syndrome caused by immune complex deposition (often anti-PLA2R antibodies) on the subepithelial side of the glomerular basement membrane. **High-Yield Clinical Pearls for NEET-PG:** * **TTP Pentad:** Fever, Microangiopathic Hemolytic Anemia (Schistocytes), Thrombocytopenia, Neurological symptoms, and Renal failure (Mnemonic: **FAT RN**) [1]. * **Diagnosis:** Decreased ADAMTS13 activity (<10%) is the definitive diagnostic marker. * **Treatment:** **Plasmapheresis (Plasma Exchange)** is the gold standard as it removes antibodies and replenishes the ADAMTS13 enzyme. * **Schistocytes:** Always look for "helmet cells" on a peripheral smear in TTP/HUS questions [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 947-948. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 667-668. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 946-947.

Question 992: A 13-year-old female attends a hematology clinic for follow-up of a coagulation defect in the extrinsic pathway. Which coagulation factor is defective?

A. VII (Correct Answer)
B. VIII
C. IX
D. XI

Explanation: **Explanation:** The coagulation cascade is traditionally divided into the intrinsic, extrinsic, and common pathways. To answer this question, one must identify which factor is unique to the **extrinsic pathway**. 1. **Why Factor VII is correct:** Factor VII is the only factor involved exclusively in the extrinsic pathway [2]. This pathway is initiated when subendothelial **Tissue Factor (Factor III)** is exposed to circulating Factor VII following vascular injury. The resulting TF-VIIa complex then activates Factor X (the start of the common pathway). In clinical practice, a defect in the extrinsic pathway is characterized by an isolated prolongation of **Prothrombin Time (PT)**, while the Activated Partial Hypotension Time (aPTT) remains normal. 2. **Why the other options are incorrect:** * **Factors VIII, IX, and XI** are all components of the **intrinsic pathway**. * Deficiencies in these factors (e.g., Hemophilia A [VIII], Hemophilia B [IX], or Hemophilia C [XI]) result in a prolonged **aPTT**, while the PT remains normal [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for PT/Extrinsic:** "PET" (PT, Extrinsic, Tissue Factor/Factor VII). * **Mnemonic for aPTT/Intrinsic:** "PITT" (PTT, Intrinsic, Twelve, Eleven, Ten, Nine, Eight—though note Factor X is common). * **Factor VII** has the **shortest half-life** (approx. 4–6 hours) among all clotting factors [1]. Therefore, PT is the first lab value to become deranged in acute liver failure or early Warfarin therapy. * **Vitamin K-dependent factors:** II, VII, IX, and X (Factor VII is the most sensitive to Vitamin K deficiency) [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 582-583. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 128-130.

Question 993: Multiple myeloma is diagnosed by which of the following criteria?

A. 24-hour urine protein measurement
B. Kidney biopsy
C. Greater than 10% plasmacytosis (Correct Answer)
D. Rouleaux formation in peripheral blood smear

Explanation: ### Explanation **Correct Option: C. Greater than 10% plasmacytosis** The diagnosis of Multiple Myeloma (MM) is based on the **International Myeloma Working Group (IMWG)** updated criteria. It requires the presence of clonal bone marrow plasma cells **≥10%** (or biopsy-proven extramedullary plasmacytoma) [1] **AND** one or more **CRAB** features (hyperCalcemia, Renal insufficiency, Anemia, Bone lesions) [1] or specific biomarkers of malignancy (e.g., plasma cells ≥60%, involved:uninvolved free light chain ratio ≥100). Plasmacytosis is the hallmark pathological finding representing the neoplastic proliferation of plasma cells in the bone marrow [1]. **Why other options are incorrect:** * **A. 24-hour urine protein measurement:** While used to detect Bence-Jones proteins (free light chains), it is a screening or monitoring tool, not a definitive diagnostic criterion for MM [2]. * **B. Kidney biopsy:** Though MM often causes "Myeloma Kidney" (cast nephropathy), a kidney biopsy is not required for diagnosis [2]. Diagnosis focuses on marrow involvement and systemic end-organ damage. * **D. Rouleaux formation:** This is a non-specific finding on a peripheral smear caused by high serum protein (paraproteins) reducing the zeta potential of RBCs [1], [2]. It suggests MM but is also seen in infections and inflammatory states. **High-Yield Clinical Pearls for NEET-PG:** * **M-Spike:** Found on Serum Protein Electrophoresis (SPEP), usually in the Gamma-globulin region (IgG > IgA). * **Skull X-ray:** Shows classic "punched-out" lytic lesions [1]. * **Blood Smear:** Rouleaux formation is common, but the background is usually "blue" due to high protein content [2]. * **Most sensitive test for bone lesions:** Whole-body MRI or PET-CT (Conventional X-rays may miss early lesions). * **Differentiating Feature:** Unlike other cancers, MM typically presents with a **normal** Alkaline Phosphatase (ALP) despite extensive bone destruction. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 617-618. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 607-608.

Question 994: Hemophilia B is due to deficiency of which clotting factor?

A. Factor VIII
B. Factor VII
C. Factor IX (Correct Answer)
D. Factor X

Explanation: **Explanation:** Hemophilia B, also known as **Christmas Disease**, is an X-linked recessive bleeding disorder caused by a deficiency of **Factor IX**. Factor IX is a vitamin K-dependent serine protease [1] that plays a critical role in the intrinsic pathway of the coagulation cascade by activating Factor X. **Analysis of Options:** * **Factor IX (Correct):** Deficiency leads to Hemophilia B. It is clinically indistinguishable from Hemophilia A, presenting with hemarthrosis (joint bleeding), muscle hematomas, and prolonged bleeding after trauma. * **Factor VIII (Incorrect):** Deficiency of Factor VIII causes **Hemophilia A** (Classic Hemophilia), which is the most common hereditary disease associated with life-threatening bleeding. * **Factor VII (Incorrect):** Deficiency of Factor VII affects the **extrinsic pathway** [1]. It is rare and typically presents with a prolonged Prothrombin Time (PT) but a normal Activated Partial Thromboplastin Time (aPTT). * **Factor X (Incorrect):** Factor X is the start of the **common pathway**. Deficiency is rare and affects both PT and aPTT [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Both Hemophilia A and B are **X-linked recessive** (affecting males; females are typically asymptomatic carriers). * **Lab Findings:** Characterized by **prolonged aPTT** with a **normal PT and normal bleeding time** (platelet function is unaffected). * **Mixing Study:** A 1:1 mixing study will **correct** the aPTT in Hemophilia, distinguishing it from disorders caused by coagulation inhibitors (like Lupus anticoagulant). * **Treatment:** Factor IX concentrate is the treatment of choice for Hemophilia B. Fresh Frozen Plasma (FFP) can be used if specific concentrates are unavailable. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 582-583.

Question 995: Ham's test is used in the screening of which of the following conditions?

A. Hereditary spherocytosis
B. G6PD deficiency
C. Paroxysmal nocturnal hemoglobinuria (Correct Answer)
D. Any hemolytic disorder

Explanation: **Explanation:** **Paroxysmal Nocturnal Hemoglobinuria (PNH)** is an acquired clonal stem cell disorder characterized by a deficiency of GPI-anchored proteins (like CD55 and CD59) on the red cell membrane [1]. These proteins normally protect cells from complement-mediated lysis [2]. **Why Option C is correct:** The **Ham’s Test (Acidified Serum Test)** is a classical diagnostic test for PNH. It is based on the principle that PNH red blood cells are hypersensitive to complement activation. When the patient's red cells are placed in acidified normal serum (pH 6.2), the alternative complement pathway is activated [1]. Due to the lack of protective proteins, PNH cells undergo significant hemolysis, confirming the diagnosis. **Why other options are incorrect:** * **A. Hereditary Spherocytosis:** Diagnosed using the **Osmotic Fragility Test** or the more modern **EMA Binding Test** (Flow cytometry). * **B. G6PD Deficiency:** Screened using the **Heinz body preparation** or the **Fluorescent spot test**; definitive diagnosis is via quantitative enzyme assay. * **D. Any hemolytic disorder:** Ham’s test is highly specific for PNH and is not a general screen for all hemolytic anemias. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** While Ham’s test is historically significant, **Flow Cytometry** (detecting absence of CD55/CD59) is now the gold standard and most sensitive test for PNH [1]. * **Sucrose Lysis Test:** Another screening test for PNH; it is sensitive but less specific than Ham's test. * **PIG-A Gene:** PNH is caused by a somatic mutation in the *PIG-A* gene [2]. * **Triad of PNH:** Hemolytic anemia, pancytopenia, and venous thrombosis (often in unusual sites like the Budd-Chiari syndrome) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 650-651. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 601-602.

Question 996: Glucose-6-phosphate dehydrogenase deficiency causes which of the following conditions?

A. Hemophilia
B. Hemolytic anemia (Correct Answer)
C. Aplastic anemia
D. Megaloblastic anemia

Explanation: **Explanation:** **Glucose-6-phosphate dehydrogenase (G6PD) deficiency** is an X-linked recessive disorder [1] and the most common enzymatic deficiency of red blood cells (RBCs) [3]. **Why Hemolytic Anemia is correct:** G6PD is the rate-limiting enzyme in the Hexose Monophosphate (HMP) shunt, which produces **NADPH** [3]. NADPH is essential for maintaining a pool of **reduced glutathione**, which protects RBCs from oxidative stress. In G6PD deficiency, oxidative triggers (like fava beans, infections, or drugs like Primaquine) lead to the oxidation of hemoglobin. This forms insoluble precipitates called **Heinz bodies**. As splenic macrophages pluck these bodies out, **"Bite cells"** (Degmacytes) are formed [1]. These damaged cells are prematurely destroyed in the spleen, leading to **episodic intravascular and extravascular hemolysis.** [1] **Why other options are incorrect:** * **Hemophilia:** This is a genetic bleeding disorder caused by deficiencies in clotting factors (Factor VIII for Hemophilia A; Factor IX for Hemophilia B), not an RBC enzyme defect. * **Aplastic anemia:** This involves pancytopenia due to bone marrow failure (hypocellular marrow), often triggered by toxins, radiation, or viral infections. * **Megaloblastic anemia:** This is caused by impaired DNA synthesis, typically due to Vitamin B12 or Folate deficiency, characterized by macro-ovalocytes and hypersegmented neutrophils. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** X-linked Recessive (mostly affects males) [2]. * **Morphology:** Heinz bodies (Supravital stain like Crystal Violet) and Bite cells (Peripheral smear) [1]. * **Triggers:** Infections (most common), Fava beans (Favism), and drugs (Sulfa drugs, Primaquine, Nitrofurantoin) [1]. * **Protective Effect:** Provides resistance against *Plasmodium falciparum* malaria. * **Timing:** Enzyme levels should not be measured during an acute hemolytic episode as young reticulocytes have normal enzyme levels, potentially yielding a false-negative result [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 642-643. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 652-654. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 638.

Question 997: Massive splenomegaly is defined if the spleen weighs greater than:

A. 500 grams
B. 1 kg (Correct Answer)
C. 1.5 kg
D. 2 kg

Explanation: **Explanation:** In pathology, splenomegaly is categorized based on the weight and size of the spleen. A normal adult spleen typically weighs between **150 and 200 grams**. **1. Why 1 kg is correct:** **Massive splenomegaly** is defined as a spleen weight exceeding **1,000 grams (1 kg)** [1]. Clinically, this usually corresponds to a spleen that crosses the midline or extends into the pelvis (more than 8 cm below the left costal margin) [2]. This degree of enlargement is characteristic of specific conditions like Chronic Myeloid Leukemia (CML), Myelofibrosis, and Visceral Leishmaniasis (Kala-azar) [2], [4], [5]. **2. Analysis of Incorrect Options:** * **500 grams:** This represents **moderate splenomegaly** (usually defined as 500g to 1000g). It is commonly seen in portal hypertension, chronic hemolytic anemias, and infectious mononucleosis. * **1.5 kg & 2 kg:** While these weights certainly qualify as massive splenomegaly, they are not the *threshold* definition. The standard pathological cutoff for "massive" begins at 1 kg [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Causes of Massive Splenomegaly (Mnemonic: "M-C-M-G"):** **M**yelofibrosis, **C**hronic Myeloid Leukemia (CML), **M**alarial cachexia/Kala-azar, **G**aucher’s disease [2], [3], [4]. * **CML** is the most common cause of massive splenomegaly in clinical practice [2]. * **Splenic Infarction:** Massive splenomegaly predisposes patients to splenic infarcts because the blood supply cannot keep pace with the rapid organ growth [2], [5]. * **Palpation:** A spleen must be enlarged **2 to 3 times** its normal size to be clinically palpable. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 632-634. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 611-612. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 162-163. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 568-569. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 628-629.

Question 998: Which of the following conditions is most likely to lead to a dry tap during bone marrow aspiration?

A. Acute lymphoblastic leukemia
B. Multiple myeloma
C. Megaloblastic anaemia
D. Idiopathic myelofibrosis (Correct Answer)

Explanation: **Explanation:** A **"Dry Tap"** occurs when bone marrow cannot be aspirated despite correct needle placement. This is typically due to either **extensive fibrosis** (which physically traps cells) or **extreme hypercellularity** (where cells are too tightly packed to be sucked into the syringe). **1. Why Idiopathic Myelofibrosis is Correct:** In Primary (Idiopathic) Myelofibrosis, there is reactive proliferation of fibroblasts triggered by cytokines (like TGF-̢̢̢̢̢̢̢Ł̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢ᐔ-β and PDGF) released from neoplastic megakaryocytes [1]. This leads to extensive **collagen deposition (fibrosis)** within the marrow space. The dense fibrotic tissue replaces the fluid marrow, making aspiration impossible [1]. This is the classic "textbook" cause of a dry tap. **2. Analysis of Incorrect Options:** * **Acute Lymphoblastic Leukemia (ALL):** While the marrow is hypercellular, it usually yields an aspirate. A dry tap can occur if the marrow is "packed" with lymphoblasts, but it is less common than in myelofibrosis. * **Multiple Myeloma:** This involves focal or diffuse infiltration of plasma cells. While it can cause bone destruction, the marrow remains aspirable in most cases unless secondary fibrosis occurs. * **Megaloblastic Anaemia:** The marrow is characteristically **hypercellular** due to ineffective erythropoiesis, but the cells are large and friable, usually resulting in an easy (though hypercellular) aspiration. **3. NEET-PG High-Yield Pearls:** * **Most common causes of Dry Tap:** Myelofibrosis, Hairy Cell Leukemia (due to reticulin fibrosis), and Metastatic Carcinoma (desmoplastic reaction). * **Diagnostic Next Step:** If a dry tap occurs, a **Bone Marrow Trephine Biopsy** must be performed to visualize the architecture and confirm fibrosis (using Silver/Reticulin stain). * **Peripheral Smear in Myelofibrosis:** Look for **Dacrocytes** (teardrop RBCs) and a **Leukoerythroblastic picture** (immature WBCs and nucleated RBCs) [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 614-616. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 628-629.

Question 999: Glycosylated hemoglobin (HbA2) levels are elevated in which of the following conditions?

A. Beta thalassemia trait (Correct Answer)
B. Sickle cell anemia
C. Hereditary spherocytosis
D. None of the above

Explanation: **Explanation:** The correct answer is **Beta thalassemia trait**. **1. Why Beta Thalassemia Trait is correct:** In Beta thalassemia, there is a genetic mutation leading to reduced or absent synthesis of $\beta$-globin chains [2]. To compensate for the lack of $\beta$-chains, the body increases the production of other globin chains. Specifically, there is a compensatory increase in $\delta$-chain synthesis, which combines with $\alpha$-chains to form **Hemoglobin A2 ($\alpha_2\delta_2$)**. In Beta thalassemia trait (minor), HbA2 levels typically rise above the normal range (usually >3.5%), serving as a diagnostic hallmark. **2. Why the other options are incorrect:** * **Sickle cell anemia:** This is caused by a point mutation in the $\beta$-globin gene (Glu $\rightarrow$ Val). While HbS is the predominant hemoglobin, HbA2 levels are generally normal or only slightly elevated, but not characteristically used for diagnosis as in Beta-thalassemia [4]. * **Hereditary spherocytosis:** This is a red cell membrane defect (deficiency of spectrin, ankyrin, etc.) rather than a hemoglobinopathy. Hemoglobin electrophoresis in these patients typically shows a normal distribution of HbA and HbA2. **3. NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Hb electrophoresis or HPLC (High-Performance Liquid Chromatography) is used to quantify HbA2. * **The "Iron Deficiency" Trap:** Iron deficiency anemia (IDA) can **falsely lower** HbA2 levels. Therefore, if a patient has co-existing IDA and Beta-thalassemia trait, the HbA2 might appear normal. Always rule out IDA before diagnosing Thalassemia trait. * **HbF:** Fetal hemoglobin ($\alpha_2\gamma_2$) may also be slightly elevated in Beta-thalassemia [1], but HbA2 is the more reliable marker for the "trait" form. * **Mentzer Index:** (MCV/RBC count) < 13 suggests Thalassemia [3], while > 13 suggests IDA. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 648. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 647-648. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 649-650. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 599-600.

Question 1000: What is MCV?

A. Normal value is 82-92 FL (Correct Answer)
B. Increased in aplastic anemia
C. Decreased in B12 deficiency
D. Normal in iron deficiency anemia

Explanation: **Explanation:** **Mean Corpuscular Volume (MCV)** is a measure of the average volume (size) of a single red blood cell. It is calculated by the formula: $(Hematocrit \times 10) / RBC \text{ count}$. **Why Option A is correct:** The normal reference range for MCV is typically **82–92 fL** (femtoliters), though some labs extend this to 80–100 fL. It is the primary parameter used to morphologically classify anemias into microcytic (<80 fL), normocytic (80–100 fL), or macrocytic (>100 fL). **Why the other options are incorrect:** * **Option B:** Aplastic anemia is typically a **normocytic** anemia (MCV is normal). While it can occasionally be mildly macrocytic [1], it is not the classic presentation. * **Option C:** Vitamin B12 deficiency causes megaloblastic anemia, which is a **macrocytic** anemia [3]. Therefore, MCV is **increased** (>100 fL), not decreased. * **Option D:** Iron deficiency anemia (IDA) is the most common cause of **microcytic** anemia. In IDA, MCV is **decreased** (<80 fL) because the lack of hemoglobin leads to additional cell divisions, resulting in smaller cells [2]. **High-Yield Clinical Pearls for NEET-PG:** * **MCV <80 fL (Microcytic):** Think **SITA** — **S**ideroblastic anemia, **I**ron deficiency, **T**halassemia, **A**nemia of chronic disease (late stage) [4]. * **MCV >100 fL (Macrocytic):** Megaloblastic (B12/Folate deficiency) vs. Non-megaloblastic (Alcoholism, Liver disease, Hypothyroidism). * **Mentzer Index:** (MCV / RBC count). If **<13**, it suggests Thalassemia trait; if **>13**, it suggests Iron Deficiency Anemia. * **RDW (Red Cell Distribution Width):** Used alongside MCV to differentiate IDA (High RDW) from Thalassemia (Normal RDW). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 662-663. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 590-591. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 588-589. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 638.

Practice by Chapter

Anemias: Classification and Approach

Practice Questions

Hemolytic Anemias

Practice Questions

Myeloproliferative Neoplasms

Practice Questions

Myelodysplastic Syndromes

Practice Questions

Acute Leukemias

Practice Questions

Chronic Leukemias

Practice Questions

Lymphomas and Lymphoid Neoplasms

Practice Questions

Plasma Cell Disorders

Practice Questions

Bleeding Disorders

Practice Questions

Thrombotic Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free